| RefNo | JV/9/5/10 |
| Level | File |
| Title | 'Utrecht', 28 - 29 August 2000 |
| Date | 21 July 2000 - 31 August 2000 |
| Description | The file contains a copy of Sir John Vane's itinerary and some detailed information relating to a hearing he attended whilst in Utrecht, and at which he gave evidence. Included in the file are copies of Sir John Vane's statement and articles pertaining to the hearing which he has annotated. The hearing concerned a legal case between Merck Sharp & Dohme and Boehringer Ingelheim regarding the NSAIDs that each marketed in the Netherlands, and whether or not Meloxicam (marketed by Boehringer Ingelheim) is a COX-2 selective NSAID. Sir John Vane attended the hearing on behalf of Boehringer Ingelheim. |
| Extent | 12 items |
| Format | Typescript and manuscript |
| AccessStatus | Open |